DOI:10.2214/AJR.06.5004-1
AJR 2006; 186:268
© American Roentgen Ray Society
Reply
Tamar Sella,
Svetlana Mironov and
Hedvig Hricak
Memorial Sloan-Kettering Cancer Center New York, NY
Hadassah University Medical Center Jerusalem, Israel
Memorial Sloan -Kettering Cancer Center New York, NY
We thank Drs. Zissin and Even-Sapir for their important insight into the
possible physiologic uptake of 18F-FDG in normal ovaries during
certain phases of the menstrual cycle. Indeed, 18F-FDG uptake has
been described in various physiologic and benign lesions in the ovaries and
elsewhere. These physiologic and benign lesions have been recognized as a
potential source of error when interpreting 18F-FDG PET studies in
oncology patients [1,
2].
As in the normal ovary, in a functioning transposed ovary of a
premenopausal woman, physiologic uptake may theoretically be encountered.
However, ovarian and peritoneal metastases are not rare in cervical cancer
patients. Evaluation of the amount of uptake, and correlation with clinical
factors and other imaging techniques, are necessary to distinguish physiologic
from pathologic uptake. Such a case is presented in figures 9 and 11 of our
article [3], with a transposed
left ovary showing strong uptake of 18F-FDG (standardized uptake
value, 20) and correlating with a predominantly solid mass on CT. Surgical
pathology proved this lesion to be a metastasis of cervical cancer.
Thus, although a physiologic process may be considered in a premenopausal
patient with a transposed ovary, careful assessment of the PET/CT
characteristics and correlation with clinical parameters and other imaging
findings are necessary to exclude a metastasis.
References
- Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign
pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography
scanning: potential for error in interpretation. Semin Nucl
Med 1996; 26:308
-314[CrossRef][Medline]
- Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir
E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in
pre- and postmenopausal patients: assessment by PET/CT. J Nucl
Med 2004; 45:266
-271[Abstract/Free Full Text]
- Sella T, Mironov S, Hricak H. Imaging of transposed ovaries in
patients with cervical carcinoma. AJR2005; 184:1602
-1610[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?